Oxford, June 26th, 2007 - Oxford Gene Technology (OGT) and Ocean Ridge Biosciences (ORB) are pleased to announce the completion of a licence agreement granting ORB access to one of OGT’s “Southern array patents”, the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays.
The granted license will enable ORB to offer complete DNA expression and microRNA profiling services, worldwide, from its US operations in Jupiter, Florida.
Sue Sutton, Vice President Licensing North America, at OGT said: “Successful discussions with ORB have concluded with the granting of this license thus enabling the company to expand their customer base and add to OGT’s growing portfolio of North American licensees.”
Senior Scientist at ORB, David Willoughby, Ph.D. is pleased with the progress of the biotechnology company, commenting: “We appreciate the opportunity to provide this fundamental invention of Edwin Southern to the general research community, both locally here in Florida and throughout the U.S. and Canada. The licence will enable us to continue with our mission of improving human health through the provision of accurate, affordable, and information-rich genomic services.”
The licence will remain valid for the patents’ lifetime. Financial details were not disclosed.
For further information, please contact:
At Oxford Gene Technology:
Nicola Booton-Mander, Marketing Manager
Oxford Gene Technology Begbroke Science Park, Sandy Lane, Yarnton Oxford OX5 1PF
T: +44 1865 856352 F: +44 1865 842116 E: licensing@ogt.co.uk
W: www.ogt.co.uk
Media Enquiries: Annabel Entress, 0207 268 3002 / a.entress@northbankcommunications.com Sarah Jeffery, 0207 268 3002 / s.jeffery@northbankcommunications.com At Ocean Ridge Biosciences: Becky A. Mercer, Ph.D. Director of Marketing Ocean Ridge Biosciences 150 S. Old Dixie Highway Jupiter, FL 33458 T: 203-464-2037 F: 561-575-4118 E: bmercer@oceanridgebio.com W: http://oceanridgebio.com/
